Maxx Chatsko

Maxx Chatsko

TMFBlacknGold

Maxx has been a contributor to Fool.com since 2013. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering.

Recent articles



Is Lexicon Pharmaceuticals a Buy?

Despite doubts over its lead drug candidate and the loss of a major partner, the company is forging ahead.




Is NextCure a Buy?

The recent volatility hasn't been ideal, but it has certainly put the newly public company on the radar of investors.








Here's Why Athenex Gained Over 43% Today

The title of a scientific abstract suggests that additional data from its lead pipeline program will bolster the case for regulatory approval.